West Nile viral infection of equids

Veterinary Microbiology

Volumn 167, Issue 1-2, 2013, Pages 168-180

  Angenvoort, J ^a   Brault, A C ^b   Bowen, R A ^c   Groschup, M H ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Equids; Flavivirus; Horses; West Nile virus

Indexed keywords

DUVAXYN; EQIP; EQUI NILE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NEUTRALIZING ANTIBODY; PROTEQ; RECOMBITEK; UNCLASSIFIED DRUG; VETERA; WEST NILE INNOVATOR; WEST NILE VACCINE;

ARTICLE; ATAXIA; BIRD; CROSS REACTION; CULEX; CULEX PIPIENS; CULEX TARSALIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EPIDEMIOLOGICAL DATA; EPIZOOTIOLOGY; EUROPEAN UNION; FASCICULATION; GEOGRAPHIC DISTRIBUTION; HORSE DISEASE; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION PREVENTION; LIMB WEAKNESS; MORTALITY; MOSQUITO; NEUROPATHOLOGY; NONHUMAN; NORTH AMERICA; RECUMBENCY; VACCINATION; VIREMIA; VIRUS DIAGNOSIS; VIRUS ENCEPHALITIS; VIRUS TRANSMISSION; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

AVES; EQUIDAE; FLAVIVIRUS; WEST NILE VIRUS;

EQUIDS; FLAVIVIRUS; HORSES; WEST NILE VIRUS;

ANIMALS; HORSE DISEASES; HORSES; PHYLOGENY; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84889089740     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.08.013     Document Type: Article

References (95)

1. Abutarbush S.M., O'Connor B.P., Clark C., Sampieri F., Naylor J.M. Clinical West Nile virus infection in 2 horses in western Canada. Can. Vet. J. [La Revue Veterinaire Canadienne] 2004, 45:315-317.
2. Aliota M.T., Jones S.A., Dupuis A.P., Ciota A.T., Hubalek Z., Kramer L.D. Characterization of Rabensburg virus, a flavivirus closely related to West Nile virus of the Japanese encephalitis antigenic group. PloS One 2012, 7:e39387.
3. APHIS West Nile virus distribution maps, 1999-2012. Annual trends in U.S. distribution of equine West Nile virus cases 2012, APHIS, http://www.aphis.usda.gov/vs/nahss/equine/wnv/wnv_distribution_maps.htm.
4. Autorino G.L., Battisti A., Deubel V., Ferrari G., Forletta R., Giovannini A., Lelli R., Murri S., Scicluna M.T. West Nile virus epidemic in horses, Tuscany region, Italy. Emerg. Infect. Dis. 2002, 8:1372-1378.
5. Bagnarelli P., Marinelli K., Trotta D., Monachetti A., Tavio M., Del Gobbo R., Capobianchi M., Menzo S., Nicoletti L., Magurano F., Varaldo P. Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. Euro Surveill. 2011, 16. pii 20002.
6. Bakonyi T., Hubalek Z., Rudolf I., Nowotny N. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg. Infect. Dis. 2005, 11:225-231.
7. Bakonyi T., Ivanics E., Erdelyi K., Ursu K., Ferenczi E., Weissenbock H., Nowotny N. Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg. Infect. Dis. 2006, 12:618-623.
8. Bakonyi T., Ferenczi E., Erdelyi K., Kutasi O., Csorgo T., Seidel B., Weissenbock H., Brugger K., Ban E., Nowotny N. Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008/2009. Vet. Microbiol. 2013, 10.1016/j.vetmic.2013.03.005.
9. Barros S.C., Ramos F., Fagulha T., Duarte M., Henriques M., Luis T., Fevereiro M. Serological evidence of West Nile virus circulation in Portugal. Vet. Microbiol. 2011, 152:407-410.
10. Beasley D.W., Li L., Suderman M.T., Barrett A.D. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002, 296:17-23.
11. Beasley D.W., Davis C.T., Estrada-Franco J., Navarro-Lopez R., Campomanes-Cortes A., Tesh R.B., Weaver S.C., Barrett A.D. Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerg. Infect. Dis. 2004, 10:2221-2224.
12. Beasley D.W., Whiteman M.C., Zhang S., Huang C.Y., Schneider B.S., Smith D.R., Gromowski G.D., Higgs S., Kinney R.M., Barrett A.D. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 west nile virus strains. J. Virol. 2005, 79:8339-8347.
13. Billoir F., de Chesse R., Tolou H., de Micco P., Gould E.A., de Lamballerie X. Phylogeny of the genus flavivirus using complete coding sequences of arthropod-borne viruses and viruses with no known vector. J. Gen. Virol. 2000, 81:781-790.
14. Bondre V.P., Jadi R.S., Mishra A.C., Yergolkar P.N., Arankalle V.A. West Nile virus isolates from India: evidence for a distinct genetic lineage. J. Gen. Virol. 2007, 88:875-884.
15. Botha E.M., Markotter W., Wolfaardt M., Paweska J.T., Swanepoel R., Palacios G., Nel L.H., Venter M. Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains. Emerg. Infect. Dis. 2008, 14:222-230.
16. Brault A.C., Huang C.Y., Langevin S.A., Kinney R.M., Bowen R.A., Ramey W.N., Panella N.A., Holmes E.C., Powers A.M., Miller B.R. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat. Genet. 2007, 39:1162-1166.
17. Brault A.C., Langevin S.A., Ramey W.N., Fang Y., Beasley D.W.C., Barker C.M., Sanders T.A., Reisen W.K., Barrett A.D.T., Bowen R.A. Reduced avian virulence and viremia of West Nile virus isolates from Mexico and Texas. Am. J. Trop. Med. Hyg. 2011, 85:758-767.
18. Bunning M.L., Bowen R.A., Cropp C.B., Sullivan K.G., Davis B.S., Komar N., Godsey M.S., Baker D., Hettler D.L., Holmes D.A., Biggerstaff B.J., Mitchell C.J. Experimental infection of horses with West Nile virus. Emerg. Infect. Dis. 2002, 8:380-386.
19. Cantile C., Del Piero F., Di Guardo G., Arispici M. Pathologic and immunohistochemical findings in naturally occuring West Nile virus infection in horses. Vet. Pathol. 2001, 38:414-421.
20. Castillo-Olivares J., Wood J. West Nile virus infection of horses. Vet. Res. 2004, 35:467-483.
21. Castillo-Olivares J., Mansfield K.L., Phipps L.P., Johnson N., Tearle J., Fooks A.R. Antibody response in horses following experimental infection with West Nile Virus lineages 1 and 2. Transbound. Emerg. Dis. 2011, 58:206-212.
22. Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990, 44:649-688.
23. Charrel R.N., Brault A.C., Gallian P., Lemasson J.J., Murgue B., Murri S., Pastorino B., Zeller H., de Chesse R., de Micco P., de Lamballerie X. Evolutionary relationship between Old World West Nile virus strains. Evidence for viral gene flow between Africa, the Middle East, and Europe. Virology 2003, 315:381-388.
24. Cook S., Moureau G., Kitchen A., Gould E., de Lamballerie X., Holmes E.C., Harbach R. Molecular evolution of the insect-specific flaviviruses. J. Gen. Virol. 2011, [pii] vir.0.036525-0. 10.1099/vir.0.036525-0.
25. Eiden M., Vina-Rodriguez A., Hoffmann B., Ziegler U., Groschup M.H. Two new real-time quantitative reverse transcription polymerase chain reaction assays with unique target sites for the specific and sensitive detection of lineages 1 and 2 West Nile virus strains. J. Vet. Diagn. Invest. 2010, 22:748-753.
26. El Garch H., Minke J.M., Rehder J., Richard S., Edlund Toulemonde C., Dinic S., Andreoni C., Audonnet J.C., Nordgren R., Juillard V. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. Vet. Immunol. Immunopathol. 2008, 123:230-239.
27. Ezenwa V.O., Godsey M.S., King R.J., Guptill S.C. Avian diversity and West Nile virus: testing associations between biodiversity and infectious disease risk. Proc. Biol. Sci. 2006, 273:109-117.
28. Frost M.J., Zhang J., Edmonds J.H., Prow N.A., Gu X., Davis R., Hornitzky C., Arzey K.E., Finlaison D., Hick P., Read A., Hobson-Peters J., May F.J., Doggett S.L., Haniotis J., Russell R.C., Hall R.A., Khromykh A.A., Kirkland P.D. Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg. Infect. Dis. 2012, 18:792-800.
29. Garcia-Bocanegra I., Jaen-Tellez J.A., Napp S., Arenas-Montes A., Fernandez-Morente M., Fernandez-Molera V., Arenas A. West Nile fever outbreak in horses and humans, Spain, 2010. Emerg. Infect. Dis. 2011, 17:2397-2399.
30. Gardner I.A., Wong S.J., Ferraro G.L., Balasuriya U.B., Hullinger P.J., Wilson W.D., Shi P.Y., MacLachlan N.J. Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California. Vet. Res. 2007, 38:109-116.
31. Goddard L.B., Roth A.E., Reisen W.K., Scott T.W. Vector competence of California mosquitoes for West Nile virus. Emerg. Infect. Dis. 2002, 8:1385-1391.
32. Guthrie A.J., Howell P.G., Gardner I.A., Swanepoel R.E., Nurton J.P., Harper C.K., Pardini A., Groenewald D., Visage C.W., Hedges J.F., Balasuriya U.B., Cornel A.J., MacLachlan N.J. West Nile virus infection of Thoroughbred horses in South Africa (2000-2001). Equine Vet. J. 2003, 35:601-605.
33. Harris E., Holden K.L., Edgil D., Polacek C., Clyde K. Molecular biology of flaviviruses. Novartis Found. Symp. 2006, 277:23-39. [discussion 40, 71-23, 251-253].
34. Heinz F., Collet M., Purcell R., Gould E., Howeard C., Houghton M. Family Flaviviridae. Virus Taxonomy: Classification and Nomenclature of Viruses 2000, 859-878. Academic Press, San Diego. M. Van Regenmortel (Ed.).
35. Hobson-Peters J., Arevalo C., Cheah W.Y., Blitvich B.J., Tan C.S., Sandis A., Araya L.N., Hernandez J.L., Toye P., Hall R.A. Detection of antibodies to West Nile virus in horses, Costa Rica, 2004. Vector Borne Zoonotic Dis. 2011, 11:1081-1084.
36. Hubalek Z., Halouzka J. West Nile fever - a reemerging mosquito-borne viral disease in Europe. Emerg. Infect. Dis. 1999, 5:643-650.
37. Jonquiere F.J., van der Heijden H.M.J.F., van Maanen C., Sloet van Oldruitenborgh-Oosterbaan M.M. West Nile Virus Vaccination in Horses - IgM and IgG responses after injection in different muscles. Pferdeheilkunde 2007, 27:412-416.
38. Keller B.C., Fredericksen B.L., Samuel M.A., Mock R.E., Mason P.W., Diamond M.S., Gale M. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J. Virol. 2006, 80:9424-9434.
39. Knox J., Cowan R.U., Doyle J.S., Ligtermoet M.K., Archer J.S., Burrow J.N., Tong S.Y., Currie B.J., Mackenzie J.S., Smith D.W., Catton M., Moran R.J., Aboltins C.A., Richards J.S. Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med. J. Aust. 2012, 196:322-326.
40. Komar N., Clark G.G. West Nile virus activity in Latin America and the Caribbean. Rev. Panam. Salud Publica. 2006, 19:112-117.
41. Kutasi O., Bakonyi T., Lecollinet S., Biksi I., Ferenczi E., Bahuon C., Sardi S., Zientara S., Szenci O. Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile virus in Hungary. J. Vet. Intern. Med./Am. Coll. Vet. Intern. Med. 2011, 25:586-591.
42. Kutzler M., Harris J., Swope C., Berrier R. Efficacy and dose response of passive administration of hyperimmunized West Nile virus serum in horses. 10th International Congress of World Equine Veterinary Association 2008, 408-409.
43. Lanciotti R.S., Roehrig J.T., Deubel V., Smith J., Parker M., Steele K., Crise B., Volpe K.E., Crabtree M.B., Scherret J.H., Hall R.A., MacKenzie J.S., Cropp C.B., Panigrahy B., Ostlund E., Schmitt B., Malkinson M., Banet C., Weissman J., Komar N., Savage H.M., Stone W., McNamara T., Gubler D.J. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999, 286:2333-2337.
44. Langevin S.A., Bowen R.A., Ramey W.N., Sanders T.A., Maharaj P.D., Fang Y., Cornelius J., Barker C.M., Reisen W.K., Beasley D.W.C., Barrett A.D.T., Kinney R.M., Huang C.Y.H., Brault A.C. Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate. J. Gen. Virol. 2011, 92:2810-2820.
45. Ledermann J.P., Lorono-Pino M.A., Ellis C., Saxton-Shaw K.D., Blitvich B.J., Beaty B.J., Bowen R.A., Powers A.M. Evaluation of widely used diagnostic tests to detect West Nile virus infections in horses previously infected with St. Louis encephalitis virus or dengue virus type 2. Clin. Vaccine Immunol. 2011, 18:580-587.
46. Long M.T. Flavivirus infections. Equine Infectious Diseases 2006, 198-206. Elsevier Health Sciences. D.C. Sellon, M. Long (Eds.).
47. Mailles A., Dellamonica P., Zeller H., Durand J.P., Zientara S., Goffette R., Gloaguen C., Armengaud A., Schaffner F., Hars J., Chodorge E., Barbat J. Human and equine West Nile virus infections in France, August-September 2003. Eurosurveillance 2003, 7. pii=2312.
48. May F.J., Davis C.T., Tesh R.B., Barrett A.D. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J. Virol. 2011, 85:2964-2974.
49. McMullen A.R., Albayrak H., May F.J., Davis C.T., Beasley D.W., Barrett A.D. Molecular evolution of lineage 2 West Nile virus. J. Gen. Virol. 2013, 94:318-325.
50. Minke J.M., Siger L., Cupillard L., Powers B., Bakonyi T., Boyum S., Nowotny N., Bowen R. Protection provided by a recombinant ALVAC((R))-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Vaccine 2011, 29:4608-4612.
51. Minke J.M., Siger L., Karaca K., Austgen L., Gordy P., Bowen R., Renshaw R.W., Loosmore S., Audonnet J.C., Nordgren B. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch. Virol. Suppl. 2004, 221-230.
52. Morales M.A., Barrandeguy M., Fabbri C., Garcia J.B., Vissani A., Trono K., Gutierrez G., Pigretti S., Menchaca H., Garrido N., Taylor N., Fernandez F., Levis S., Enria D. West Nile virus isolation from equines in Argentina, 2006. Emerg. Infect. Dis. 2006, 12:1559-1561.
53. Munoz J., Ruiz S., Soriguer R., Alcaide M., Viana D.S., Roiz D., Vazquez A., Figuerola J. Feeding patterns of potential West Nile virus vectors in south-west Spain. PloS One 2012, 7:e39549.
54. Murata R., Eshita Y., Maeda A., Maeda J., Akita S., Tanaka T., Yoshii K., Kariwa H., Umemura T., Takashima I. Glycosylation of the West Nile Virus envelope protein increases in vivo and in vitro viral multiplication in birds. Am. J. Trop. Med. Hyg. 2010, 82:696-704.
55. Murgue B., Murri S., Triki H., Deubel V., Zeller H.G. West Nile in the Mediterranean basin: 1950-2000. Ann. N. Y. Acad. Sci. 2001, 951:117-126.
56. Murgue B., Murri S., Zientara S., Durand B., Durand J.P., Zeller H. West Nile outbreak in horses in southern France, 2000: the return after 35 years. Emerg. Infect. Dis. 2001, 7:692-696.
57. Ng T., Hathaway D., Jennings N., Champ D., Chiang Y.W., Chu H.J. Equine vaccine for West Nile virus. Dev. Biol. 2003, 114:221-227.
58. Nielsen C.F., Reisen W.K., Armijos M.V., Maclachlan N.J., Scott T.W. High subclinical West Nile virus incidence among nonvaccinated horses in northern California associated with low vector abundance and infection. Am. J. Trop. Med. Hyg. 2008, 78:45-52.
59. OIE, 2012. Summary of immediate notifications and follow-ups - West Nile Fever. http://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/Immsummary.
60. Ostlund E.N., Crom R.L., Pedersen D.D., Johnson D.J., Williams W.O., Schmitt B.J. Equine West Nile encephalitis, United States. Emerg. Infect. Dis. 2001, 7:665-669.
61. Pantheir R., Hannoun C., Oudar J., Beytout D., Corniou B., Joubert L., Guillon J.C., Mouchet J. [Isolation of West Nile virus in a Camarge horse with encephalomyelitis]. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 1966, 262:1308-1310.
62. Papa A. West Nile virus infections in Greece: an update. Expert Rev. Anti. Infect. Ther. 2012, 10:743-750.
63. Papa A., Danis K., Athanasiadou A., Delianidou M., Panagiotopoulos T. Persistence of West Nile virus immunoglobulin M antibodies, Greece. J. Med. Virol. 2011, 83:1857-1860.
64. Platonov A.E. West Nile encephalitis in Russia 1999-2001: were we ready? Are we ready?. Ann. N. Y. Acad. Sci. 2001, 951:102-116.
65. Platonov A.E., Karan L.S., Shopenskaia T.A., Fedorova M.V., Koliasnikova N.M., Rusakova N.M., Shishkina L.V., Arshba T.E., Zhuravlev V.I., Govorukhina M.V., Valentseva A.A., Shipulin G.A. [Genotyping of West Nile fever virus strains circulating in southern Russia as an epidemiological investigation method: principles and results]. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 2011, 29-37.
66. Porter M.B., Long M.T., Getman L.M., Giguere S., MacKay R.J., Lester G.D., Alleman A.R., Wamsley H.L., Franklin R.P., Jacks S., Buergelt C.D., Detrisac C.J. West Nile virus encephalomyelitis in horses: 46 cases (2001). J. Am. Vet. Med. Assoc. 2003, 222:1241-1247.
67. Prilipov A.G., Samokhvalov E.I., L'Vov D.K., Gromashevskii V.L., Butenko A.M., Vyshemirskii O.I., Larichev V.F., Gaidamovich S., Khutoretskaia N.V., Voronina A.G., Novikov D.V., Mokhonov V.V., Al'khovskii S.V. [Genetic analysis of West Nile fever virus, isolated in the south of the Russian plain (Volgograd and Astrakhan regions) in 1999]. Vopr. Virusol. 2001, 46:8-12.
68. Rios J.J., Fleming J.G., Bryant U.K., Carter C.N., Huber J.C., Long M.T., Spencer T.E., Adelson D.L. OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses. PloS One 2010, 5:e10537.
69. Robinson N.N.E., Sprayberry K.A. Current Therapy in Equine Medicine 6 2009, p. 624. Elsevier Limited, Oxford.
70. Roehrig J.T., Nash D., Maldin B., Labowitz A., Martin D.A., Lanciotti R.S., Campbell G.L. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases. Emerg. Infect. Dis. 2003, 9:376-379.
71. Rushton J.O., Lecollinet S., Hubálek Z., Svobodová P., Lussy H., Nowotny N. Tick-borne encephalitis virus in horses, Austria, 2011. Emerg. Infect. Dis. 2013, 19:635-637. (Internet).
72. Salazar P., Traub-Dargatz J.L., Morley P.S., Wilmot D.D., Steffen D.J., Cunningham W.E., Salman M.D. Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. J. Am. Vet. Med. Assoc. 2004, 225:267-274.
73. Samuel M.A., Diamond M.S. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 2005, 79:13350-13361.
74. Samuel M.A., Diamond M.S. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 2006, 80:9349-9360.
75. Savini G., Capelli G., Monaco F., Polci A., Russo F., Di Gennaro A., Marini V., Teodori L., Montarsi F., Pinoni C., Pisciella M., Terregino C., Marangon S., Capua I., Lelli R. Evidence of West Nile virus lineage 2 circulation in Northern Italy. Vet. Microbiol. 2012, 158:267-273.
76. Schmidt J.R., Elmansoury H.K. Natural and experimental infection of egyptian equines with west nile virus. Ann. Trop. Med. Parasitol. 1963, 57:415-427.
77. Schuler L.A., Khaitsa M.L., Dyer N.W., Stoltenow C.L. Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002). J. Am. Vet. Med. Assoc. 2004, 225:1084-1089.
78. Sebastian M.M., Stewart I., Williams N.M., Poonacha K.B., Sells S.F., Vickers M.L., Harrison L.R. Pathological, entomological, avian and meteorological investigation of a West Nile virus epidemic in a horse farm. Transbound. Emerg. Dis. 2008, 55:134-139.
79. Seino K.K., Long M.T., Gibbs E.P., Bowen R.A., Beachboard S.E., Humphrey P.P., Dixon M.A., Bourgeois M.A. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model. Clin. Vaccine Immunol. 2007, 14:1465-1471.
80. Siger L., Bowen R., Karaca K., Murray M., Jagannatha S., Echols B., Nordgren R., Minke J.M. Evaluation of the efficacy provided by a recombinant canarypox-vectored equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses. Vet. Ther. Res. Appl. Vet. Med. 2006, 7:249-256.
81. Siger L., Bowen R.A., Karaca K., Murray M.J., Gordy P.W., Loosmore S.M., Audonnet J.C., Nordgren R.M., Minke J.M. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses. Am. J. Vet. Res. 2004, 65:1459-1462.
82. Sirbu A., Ceianu C.S., Panculescu-Gatej R.I., Vazquez A., Tenorio A., Rebreanu R., Niedrig M., Nicolescu G., Pistol A. Outbreak of West Nile virus infection in humans, Romania, July to October 2010. Euro Surveill. 2011, 16. pii=19762.
83. Smithburn K.C., Hughes T.P., Burke A.W., Paul J.H. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. Hyg. 1940, s1-20:471-492.
84. Steinman A., Banet C., Sutton G.A., Yadin H., Hadar S., Brill A. Clinical signs of West Nile virus encephalomyelitis in horses during the outbreak in Israel in 2000. Vet. Rec. 2002, 151:47-49.
85. Swaddle J.P., Calos S.E. Increased avian diversity is associated with lower incidence of human West Nile infection: observation of the dilution effect. PLoS ONE 2008, 3:e2488.
86. Tee S., Horadagoda N., Mogg T. Kunjin flaviviral encephalomyelitis in an Arabian gelding in New South Wales, Australia. Aust. Vet. J. 2012, 90:321-324.
87. Trock S.C., Meade B.J., Glaser A.L., Ostlund E.N., Lanciotti R.S., Cropp B.C., Kulasekera V., Kramer L.D., Komar N. West Nile virus outbreak among horses in New York State, 1999 and 2000. Emerg. Infect. Dis. 2001, 7:745-747.
88. Tsai T.F., Popovici F., Cernescu C., Campbell G.L., Nedelcu N.I. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998, 352:767-771.
89. Turell M.J., Dohm D.J., Mores C.N., Terracina L., Wallette D.L., Hribar L.J., Pecor J.E., Blow J.A. Potential for North American mosquitoes to transmit Rift Valley fever virus. J. Am. Mosq. Control Assoc. 2008, 24:502-507.
90. United States Department of Agriculture, A.P.H.I.S. Equine West Nile Virus Cases 2012, USDA, http://www.aphis.usda.gov/vs/nahss/equine/wnv/index.htm.
91. Venter M., Swanepoel R. West Nile Virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in Southern Africa. Vector-Borne Zoonotic Dis. 2010, 10:659-664.
92. Venter M., Human S., Zaayman D., Gerdes G.H., Williams J., Steyl J., Leman P.A., Paweska J.T., Setzkorn H., Rous G., Murray S., Parker R., Donnellan C., Swanepoel R. Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg. Infect. Dis. 2009, 15:877-884.
93. Ward M.P., Scheurmann J.A. The relationship between equine and human West Nile virus disease occurrence. Vet. Microbiol. 2008, 129:378-383.
94. Westaway E.G., Brinton M.A., Gaidamovich S., Horzinek M.C., Igarashi A., Kaariainen L., Lvov D.K., Porterfield J.S., Russell P.K., Trent D.W. Flaviviridae. Intervirology 1985, 24:183-192.
95. Ziegler U., Seidowski D., Angenvoort J., Eiden M., Müller K., Nowotny N., Groschup M.H. Monitoring of West Nile Virus Infections in Germany. Zoonoses Public Health 2012, 59:95-101.